Publications by authors named "Drew Levy"

Claim this Profile
L
Long-term management strategies for pegvaliase use in phenylketonuria: Lessons learned from the phase-3 PRISM open-label extension study.
Cary O Harding, Kaleigh Bulloch Whitehall, Joshua Lilienstein, Ogun Sazova, Kristin Lindstrom, Drew G Levy

Genet Med· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pegvaliase for the treatment of phenylketonuria: Final results of a long-term phase 3 clinical trial program.
Cary O Harding, Nicola Longo, Hope Northrup, Stephanie Sacharow, Rani Singh, Drew G Levy

Mol Genet Metab Rep· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term comparative effectiveness of pegvaliase versus medical nutrition therapy with and without sapropterin in adults with phenylketonuria.
Barbara K Burton, Gillian E Clague, Cary O Harding, Ece Kucuksayrac, Drew G Levy

Mol Genet Metab· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting age- and dose-related responses to antihypertensive therapy: pooled analysis of two randomized clinical trials of valsartan alone and combined with hydrochlorothiazide.
Henry R Black, Drew Griffin Levy, Nora Crikelair, Ricardo Rocha

J Am Soc Hypertens· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of baseline blood pressure in guiding treatment choice: a secondary analysis of the use of valsartan/hydrochlorothiazide as initial therapy in hypertensive adults in a randomized, double-blind, placebo-controlled trial.
James L Pool, Robert Glazer, Nora Crikelair, Drew Levy

Clin Drug Investig· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of add-on therapy with amlodipine in hypertensive patients receiving valsartan.
Derek Weycker, Abdulkadir Keskinaslan, Drew Griffin Levy, John Edelsberg, Alex Kartashov

Blood Press Suppl· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initial combination therapy compared with monotherapy in diabetic hypertensive patients.
James R Sowers, Guido Lastra, Ricardo Rocha, Yodit Seifu, Nora Crikelair, Drew G Levy

J Clin Hypertens (Greenwich)· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood pressure control in patients initiating antihypertensive therapy.
Derek Weycker, John Edelsberg, Gabor Vincze, Drew Griffin Levy, Alex Kartashov

Ann Pharmacother· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time to achieve blood-pressure goal: influence of dose of valsartan monotherapy and valsartan and hydrochlorothiazide combination therapy.
Matthew R Weir, Drew Levy, Nora Crikelair, Ricardo Rocha, Xiangyi Meng

Am J Hypertens· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the dose response with valsartan and valsartan/hydrochlorothiazide in patients with essential hypertension.
Matthew R Weir, Nora Crikelair, Drew Levy, Ricardo Rocha, Venkatram Kuturu

J Clin Hypertens (Greenwich)· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis